A 24 Month, Multicenter, Randomized, Open-label Safety and Efficacy Study of Concentration-controlled Everolimus With Reduced Calcineurin Inhibitor vs Mycophenolate With Standard Calcineurin Inhibitor in de Novo Renal Transplantation
A 24 Month, Multicenter, Randomized, Open-label Safety and Efficacy Study of Concentration-controlled Everolimus With Reduced Calcineurin Inhibitor vs Mycophenolate With Standard Calcineurin Inhibitor in de Novo Renal Transplantation
This is a 2-year, randomized, multicenter, open-label, 2-arm study evaluating the graft function of everolimus and reduced CNI versus MPA and standard CNI in adult de novo renal transplant recipients.
Inclusion Criteria:
Exclusion Criteria:
CABA, Buenos Aires C1181ACH, Argentina
Hannover Muenden, 34346, Germany
Selangor Darul Ehsan, 68100, Malaysia
Szczecin, Pomeranian Voivodeship 70-111, Poland
Mecidiyekoy/Istanbul, 34394, Turkey (Türkiye)